Literature DB >> 22270167

Optimized planning target volume for intact cervical cancer.

Alvin Khan1, Lindsay G Jensen, Shuai Sun, William Y Song, Catheryn M Yashar, Arno J Mundt, Fu-Quan Zhang, Steve B Jiang, Loren K Mell.   

Abstract

PURPOSE: To model interfraction clinical target volume (CTV) variation in patients with intact cervical cancer and design a planning target volume (PTV) that minimizes normal tissue dose while maximizing CTV coverage. METHODS AND MATERIALS: We analyzed 50 patients undergoing external-beam radiotherapy for intact cervical cancer using daily online cone-beam computed tomography (CBCT). The CBCTs (n = 972) for each patient were rigidly registered to the planning CT. The CTV was delineated on the planning CT (CTV(0)) and the set of CBCTs ({CTV(1)-CTV(25)}). Manual (n = 98) and automated (n = 668) landmarks were placed over the surface of CTV(0) with reference to defined anatomic structures. Normal vectors were extended from each landmark, and the minimum length required for a given probability of encompassing CTV(1)-CTV(25) was computed. The resulting expansions were used to generate an optimized PTV.
RESULTS: The mean (SD; range) normal vector length to ensure 95% coverage was 4.3 mm (2.7 mm; 1-16 mm). The uniform expansion required to ensure 95% probability of CTV coverage was 13 mm. An anisotropic margin of 20 mm anteriorly and posteriorly and 10 mm superiorly, inferiorly, and laterally also would have ensured a 95% probability of CTV coverage. The volume of the 95% optimized PTV (1470 cm(3)) was significantly lower than both the anisotropic PTV (2220 cm(3)) and the uniformly expanded PTV (2110 cm(3)) (p < 0.001). For a 95% probability of CTV coverage, normal lengths of 1-3 mm were found along the superior and lateral regions of CTV(0), 5-10 mm along the interfaces of CTV(0) with the bladder and rectum, and 10-14 mm along the anterior surface of CTV(0) at the level of the uterus.
CONCLUSION: Optimizing PTV definition according to surface landmarking resulted in a high probability of CTV coverage with reduced PTV volumes. Our results provide data justifying planning margins to use in practice and clinical trials.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22270167     DOI: 10.1016/j.ijrobp.2011.10.027

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  6 in total

Review 1.  Problems and solutions in IGRT for cervical cancer.

Authors:  Iván Ríos; Ilse Vásquez; Elsa Cuervo; Óscar Garzón; Johnny Burbano
Journal:  Rep Pract Oncol Radiother       Date:  2018-05-26

2.  Simultaneous integrated boost (SIB) of the parametrium and cervix in radiotherapy for uterine cervical carcinoma: a dosimetric study using a new alternative approach.

Authors:  Jen-Yu Cheng; Eng-Yen Huang; Shun-Neng Hsu; Chong-Jong Wang
Journal:  Br J Radiol       Date:  2016-10-06       Impact factor: 3.039

3.  Variability in clinical target volume delineation for intensity modulated radiation therapy in 3 challenging cervix cancer scenarios.

Authors:  Karen Lim; Beth Erickson; Ina M Jürgenliemk-Schulz; David Gaffney; Carien L Creutzberg; Akila Viswanathan; Lorraine Portelance; Sushil Beriwal; Aaron Wolfson; Walter Bosch; Jennifer De Los Santos; Catheryn Yashar; Anuja Jhingran; Mahesh Varia; Issam El Naqa; Bronwyn King; Anthony Fyles
Journal:  Pract Radiat Oncol       Date:  2015-07-02

4.  Prospective Validation of a High Dimensional Shape Model for Organ Motion in Intact Cervical Cancer.

Authors:  Casey W Williamson; Garrett Green; Sonal S Noticewala; Nan Li; Hanjie Shen; Florin Vaida; Loren K Mell
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-08-22       Impact factor: 7.038

5.  Magnetic Resonance-guided External Beam Radiation and Brachytherapy for a Patient with Intact Cervical Cancer.

Authors:  David Asher; Kyle R Padgett; Ricardo E Llorente; Benjamin S Farnia; John C Ford; Shefali R Gajjar; Shahil Mehta; Garrett N Simpson; Nesrin Dogan; Lorraine Portelance
Journal:  Cureus       Date:  2018-05-04

6.  Whole-pelvic radiotherapy with spot-scanning proton beams for uterine cervical cancer: a planning study.

Authors:  Shingo Hashimoto; Yuta Shibamoto; Hiromitsu Iwata; Hiroyuki Ogino; Hiroki Shibata; Toshiyuki Toshito; Chikao Sugie; Jun-Etsu Mizoe
Journal:  J Radiat Res       Date:  2016-07-05       Impact factor: 2.724

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.